focus -WSS

focus

author：hotspot 2025-09-05 05:04:58 - browse：94684

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

In a clinical trial, Casgevy was shown to eliminate recurrent episodes of debilitating pain caused by sickle cell, which afflicts approximately 100,000 people in the U.S., a vast majority of whom are Black. The therapy, whose scientific name is exa-cel, is described as a potential cure because the genetic fix enabled by CRISPR is designed to last a lifetime, although confirmation will require years of follow-up.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Pioneering cancer drug will cost $475,000. Analysts call it a bargain

knowledge

leisure time

WSS

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

CRISPR pioneers react to Casgevy, first gene

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

A daunting task: navigating dual Medicare, Medicaid eligibility

NYU radiologists take on the challenge of expensive MRI machines

David Sabatini, ex

hotspot

focus

focus

Cancer drug shortages should be causing more outrage

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Bright Health sells Medicare Advantage business to Molina

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

At least 13 dead in Texas as scorching temps continue

World's first CRISPR

Apple is now the first public company to be valued at $3 trillion

David Sabatini, ex

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout LOUD podcast: A CRISPR milestone, biotech mixology

knowledge

A public health expert passes on football's full body collisions for youths

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Gain of function research would be limited under House proposal

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

hotspot

knowledge

leisure time

Wikipedia